BioSpace News Archive

IVERIC bio, Inc. reported that on December 1, 2021, the Company granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to six newly-hired, non-executive employees.

IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, is launching new Research Nursing and Phlebotomy services.

Albireo Pharma, Inc., a rare liver disease company developing novel bile acid modulators, announced the appointment of Constantine Chinoporos as Chief Business Officer and a member of the Albireo Enterprise Leadership Team.

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing targeted therapies for cardiovascular diseases, today announced that enrollment has been completed in ASPEN-COVID-19, the Phase 2b clinical trial evaluating rNAPc2 as a potential treatment for patients hospitalized with COVID-19.

Code Biotherapeutics, Inc., a biotechnology company pioneering targeted non-viral delivery of genetic medicines, announces the appointment of Erin Brubaker as Chief Operating Officer, effective immediately.

Omnicell, Inc. (Nasdaq:OMCL), today announced it has entered into a definitive agreement with ReCept Holdings, Inc., a leading provider of specialty pharmacy management services for health systems, clinics, and physician groups, to acquire its business for total aggregate cash consideration of $100 million, subject to customary adjustments.

Horizon Therapeutics plc announced that it has been named to Great Place to Work’s 2021 Best Workplaces for Parents list, which highlights companies that have created consistently positive experiences for working parents.

Celcuity Inc., a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating patients with cancer, announced that an abstract has been accepted for poster presentation at the 2021 San Antonio Breast Cancer Symposium, which is being held virtually and in-person from December 7-10, 2021.

Lewis Pharmaceutical Information, Inc., announces the U.S. Patent Office has granted Patent No. US 10,777,322 B2 to a patient-centric system and platform called Comprehensive Medication Analysis (CMA) (https://www.cmalpi.com).

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, today announces the successful completion of the first surgery in the U.S. utilizing Pixee Medical, an FDA-cleared augmented reality surgical application for assistance in total knee arthroplasties.